piRNA28846 has the potential to be a novel RNA nucleic acid drug for ovarian cancer

Abstract Conventional targeted therapies primarily rely on small molecules and proteins. However, they often struggle to enter specific protein conformations, which limits their therapeutic effectiveness. In contrast, RNA therapy is emerging as a more precise and effective targeting strategy. Throug...

Full description

Saved in:
Bibliographic Details
Main Authors: Hong-lei Qin, Yang Han, Jian-qi Li, Qing-hua Wu, Yu-ping Du, Qian-hui Li, Xi Chen, Yong-peng Wang, Xue Guan, Xiu-jie Sheng, Shuo Chen, Yang Zhao
Format: Article
Language:English
Published: Nature Portfolio 2025-03-01
Series:npj Precision Oncology
Online Access:https://doi.org/10.1038/s41698-025-00840-w
Tags: Add Tag
No Tags, Be the first to tag this record!